Literature DB >> 30649487

Challenges and opportunities in meningiomas: recommendations from the International Consortium on Meningiomas.

Farshad Nassiri1,2, Ghazaleh Tabatabai3, Kenneth Aldape2,4, Gelareh Zadeh1.   

Abstract

Entities:  

Year:  2019        PMID: 30649487      PMCID: PMC6347075          DOI: 10.1093/neuonc/noy181

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  6 in total

1.  Survival in patients treated for anaplastic meningioma.

Authors:  Jennifer Moliterno; William P Cope; Emma D Vartanian; Anne S Reiner; Roselyn Kellen; Shahiba Q Ogilvie; Jason T Huse; Philip H Gutin
Journal:  J Neurosurg       Date:  2015-04-10       Impact factor: 5.115

2.  The CBTRUS story: providing accurate population-based statistics on brain and other central nervous system tumors for everyone.

Authors:  Carol Kruchko; Quinn T Ostrom; Haley Gittleman; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2018-02-19       Impact factor: 12.300

3.  Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.

Authors:  Victoria E Clark; E Zeynep Erson-Omay; Akdes Serin; Jun Yin; Justin Cotney; Koray Ozduman; Timuçin Avşar; Jie Li; Phillip B Murray; Octavian Henegariu; Saliha Yilmaz; Jennifer Moliterno Günel; Geneive Carrión-Grant; Baran Yilmaz; Conor Grady; Bahattin Tanrikulu; Mehmet Bakircioğlu; Hande Kaymakçalan; Ahmet Okay Caglayan; Leman Sencar; Emre Ceyhun; A Fatih Atik; Yaşar Bayri; Hanwen Bai; Luis E Kolb; Ryan M Hebert; S Bulent Omay; Ketu Mishra-Gorur; Murim Choi; John D Overton; Eric C Holland; Shrikant Mane; Matthew W State; Kaya Bilgüvar; Joachim M Baehring; Philip H Gutin; Joseph M Piepmeier; Alexander Vortmeyer; Cameron W Brennan; M Necmettin Pamir; Türker Kiliç; Richard P Lifton; James P Noonan; Katsuhito Yasuno; Murat Günel
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

4.  Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas.

Authors:  Victoria E Clark; Akdes Serin Harmancı; Hanwen Bai; Mark W Youngblood; Tong Ihn Lee; Jacob F Baranoski; A Gulhan Ercan-Sencicek; Brian J Abraham; Abraham S Weintraub; Denes Hnisz; Matthias Simon; Boris Krischek; E Zeynep Erson-Omay; Octavian Henegariu; Geneive Carrión-Grant; Ketu Mishra-Gorur; Daniel Durán; Johanna E Goldmann; Johannes Schramm; Roland Goldbrunner; Joseph M Piepmeier; Alexander O Vortmeyer; Jennifer Moliterno Günel; Kaya Bilgüvar; Katsuhito Yasuno; Richard A Young; Murat Günel
Journal:  Nat Genet       Date:  2016-08-22       Impact factor: 38.330

5.  Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.

Authors:  Leland Rogers; Peixin Zhang; Michael A Vogelbaum; Arie Perry; Lynn S Ashby; Jignesh M Modi; Anthony M Alleman; James Galvin; David Brachman; Joseph M Jenrette; John De Groot; Joseph A Bovi; Maria Werner-Wasik; Jonathan P S Knisely; Minesh P Mehta
Journal:  J Neurosurg       Date:  2017-10-06       Impact factor: 5.115

6.  Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.

Authors:  Priscilla K Brastianos; Peleg M Horowitz; Sandro Santagata; Robert T Jones; Aaron McKenna; Gad Getz; Keith L Ligon; Emanuele Palescandolo; Paul Van Hummelen; Matthew D Ducar; Alina Raza; Ashwini Sunkavalli; Laura E Macconaill; Anat O Stemmer-Rachamimov; David N Louis; William C Hahn; Ian F Dunn; Rameen Beroukhim
Journal:  Nat Genet       Date:  2013-01-20       Impact factor: 38.330

  6 in total
  1 in total

1.  How should we manage incidental meningiomas?

Authors:  Farshad Nassiri; Gelareh Zadeh
Journal:  Neuro Oncol       Date:  2020-02-20       Impact factor: 12.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.